Synaptrix: Funding, Investors & Team (Oct 2026)
Synaptrix, a spin-out medical device company, is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management. Our proprietary NOVABLOC™ system is a procedure-based solution that delivers a novel type of electrical stimulation to selectively blocks pain signal transmission. Through human feasibility studies we have demonstrated 20+ days of pain relief with a single treatment, while sparing motor function, touch and proprioception. Synaptrix aims to receive FDA clearance in 2026 and begin commercialization of the NOVABLOC™ system.
Synaptrix has raised $10.0M across 1 funding round on record, the most recent a Series A of $10.0M announced in Nov 2024.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Synaptrix Company Profile and Key Stats
Latest funding round on record: Nov 2024.
Synaptrix Funding Rounds
Synaptrix Founders and Leadership Team
No contact details are on record for this team yet.
Synaptrix Funding Compared to Other Health Care Startups
Synaptrix's latest round of $10.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Synaptrix in Health Care and Alpharetta
Companies Similar to Synaptrix
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Synaptrix Funding FAQs
What does Synaptrix do?
Synaptrix, a spin-out medical device company, is focused on developing and commercializing drug-free, long-lasting solutions for post-operative pain management. Our proprietary NOVABLOC™ system is a procedure-based solution that delivers a novel type of electrical stimulation to selectively blocks pain signal transmission. Through human feasibility studies we have demonstrated 20+ days of pain relief with a single treatment, while sparing motor function, touch and proprioception. Synaptrix aims to receive FDA clearance in 2026 and begin commercialization of the NOVABLOC™ system.
How much funding has Synaptrix raised?
Synaptrix has raised $10.0M across 1 round on record. The most recent is a Series A of $10.0M announced in Nov 2024.
When did Synaptrix last raise funding?
Synaptrix's most recent funding round on record is a Series A of $10.0M, announced in Nov 2024.
Who founded Synaptrix?
FundedIQ lists Aryan Govil (Founder) at Synaptrix.
Where is Synaptrix headquartered?
Synaptrix is based in Alpharetta, Georgia, United States.
How many employees does Synaptrix have?
Synaptrix is in the 1-10 employee band.
How does Synaptrix's funding compare to other Health Care startups?
Synaptrix's latest round of $10.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Synaptrix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Synaptrix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.